In the presentation Mould and Alzheimer’s: An Unacknowledged Pandemic, Dale Bredesen, M.D., explains how mycotoxins participate in cellular damage during the emergence of complex chronic diseases such as Alzheimer’s. Symptoms that seem specific to mycotoxin-associated Alzheimer’s include a negative Apo-E(4), low GSH, Zn, and triglycerides as well as chronic headache and/or sinusitis.
Dr Bredesen dives deep into the cellular processes underlying the development of Alzheimer’s, emphasizing that the disease process begins in the patient decades before it can be observed in behaviour or in the standard tests. He also points out that the various drug monotherapies for Alzheimer’s have only marginally slowed the degenerative process and lists 36 contributors to Alzheimer’s development and six subtypes of the disease.
